Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Vermilion Energy
VET
$1.72B
| $4.34M | 0.01% |
115,788
+107,500
| +1,297% | +$4.25M |
|
|
FENG
1777
Phoenix New Media
FENG
$18.4M
| $4.34M | 0.01% |
207,417
+1,050
| +0.5% | +$22.3K |
|
|
AVHI
1778
DELISTED
A V Homes, Inc.
AVHI
| $4.32M | 0.01% |
262,300
-20,400
| -7% | -$342K |
|
|
RT
1779
DELISTED
Ruby Tuesday Georgia
RT
| $4.3M | 0.01% |
1,531,369
-352,500
| -19% | -$768K |
|
|
ADAP
1780
DELISTED
Adaptimmune Therapeutics
ADAP
| $4.3M | 0.01% |
780,800
+335,700
| +75% | +$1.47M |
|
1781
Progress Software
PRGS
$1.83B
| $4.3M | 0.01% |
148,011
+41,611
| +39% | +$1.21M |
|
|
SIFI
1782
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
| $4.29M | 0.01% |
305,309
+10,509
| +4% | +$154K |
|
1783
John B. Sanfilippo & Son
JBSS
$1.01B
| $4.29M | 0.01% |
58,600
+23,329
| +66% | +$1.54M |
|
1784
Lifetime Brands
LCUT
$220M
| $4.28M | 0.01% |
213,100
+73,100
| +52% | +$1.2M |
|
|
YRD
1785
Yiren Digital
YRD
$105M
| $4.28M | 0.01% |
170,600
+118,000
| +224% | +$2.83M |
|
1786
Asure Software
ASUR
$251M
| $4.27M | 0.01% |
415,476
+13,600
| +3% | +$149K |
|
|
NUVA
1787
DELISTED
NuVasive, Inc.
NUVA
| $4.27M | 0.01% |
+57,188
| New | +$4.15M |
|
1788
First Business Financial Services
FBIZ
$601M
| $4.25M | 0.01% |
163,900
+9,378
| +6% | +$233K |
|
|
NEFF
1789
DELISTED
Neff Corporation
NEFF
| $4.25M | 0.01% |
218,300
+117,600
| +117% | +$1.84M |
|
|
WPG
1790
DELISTED
Washington Prime Group Inc.
WPG
| $4.24M | 0.01% |
54,189
-170,689
| -76% | -$14.3M |
|
1791
Lakeland Industries
LAKE
$117M
| $4.23M | 0.01% |
393,202
+8,400
| +2% | +$88.8K |
|
1792
Aware
AWRE
$26.4M
| $4.22M | 0.01% |
898,887
-16,385
| -2% | -$88.1K |
|
1793
ONE Gas
OGS
$5.09B
| $4.22M | 0.01% |
62,500
+12,800
| +26% | +$830K |
|
|
ABAX
1794
DELISTED
Abaxis Inc
ABAX
| $4.22M | 0.01% |
87,101
-43,399
| -33% | -$2.15M |
|
|
CNXM
1795
DELISTED
CNX Midstream Partners LP
CNXM
| $4.22M | 0.01% |
178,800
+23,387
| +15% | +$541K |
|
|
FFWM
1796
DELISTED
First Foundation Inc
FFWM
| $4.21M | 0.01% |
271,280
-62,340
| -19% | -$954K |
|
1797
KNOT Offshore Partners
KNOP
$366M
| $4.21M | 0.01% |
180,500
+92,444
| +105% | +$2.06M |
|
1798
Natural Alternatives International
NAII
$13.6M
| $4.2M | 0.01% |
476,900
-2,400
| -0.5% | -$24.4K |
|
|
TCF
1799
DELISTED
TCF Financial Corporation Common Stock
TCF
| $4.19M | 0.01% |
81,975
-32,800
| -29% | -$1.7M |
|
|
USG
1800
DELISTED
Usg
USG
| $4.19M | 0.01% |
131,800
-176,000
| -57% | -$5.6M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.